ClinicalTrials.govpublic full text
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
deep vein thrombosis, residual vein thrombosis, optimal duration, oral anticoagulants, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884834
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.